Introduction
Gastric cancer is one of the most common and aggressive forms in China [1] . Patients with gastric cancer are often given a poor prognosis due to the difficulty of early diagnosis with highly growth and high rate of recurrence [2, 3] .
It has been suggested that the abnormal expression of check point genes can always be found in tumorgenesis, including TP53, P27 Kip1 , P21 Cip2 , P16 Ink1 and C-Myc [4] [5] [6] [7] [8] . P27 Kip1 , also known as Cyclin-dependent kinase inhibitor 1B, binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1 stage [9] . It is always thought the inhibitor of cell cycle with a tumor suppressor [10, 11] . In cancers it is often inactivated via impaired synthesis, accelerated degradation, or mislocalization [12] . We previously reported that FoxM1, the main positive regulator of cell cycle, can regulate gastric cancer cells proliferation and senescence through inhibition of P27 Kip1 [13, 14] . These observations support that P27 Kip1 is strongly negatively correlated with gastric carcinogenesis. It is important to better understand the regulation of P27 Kip1 expression in tumorgenesis for anti-cancer therapy. Currently, microRNAs (miRNAs) has been thought one of the most important regulators in tumorgeneis [15] [16] [17] [18] . MiRNAs are the small non-translated RNA molecules with approximately 18-24 nucleotides in length. Every miRNA can directly bind to the complementary sequence on the 3′-untranslated region (3′-UTR) of many possible target mRNAs, which thus regulates the genes expression by post-transcriptional gene silencing, producing sequence specific mRNA cleavage, or translational repression [19, 20] . MiRNAs can be the tumor suppressors or oncogenes which are determined by the functions of their target genes [21, 22] . There are only a few research on the miRNAs regulation on P27
Kip1 expression in tumorgenesis, including miR-221/222 [23, 24] . We still need more evidence on specific miRNA regulation on P27 Kip1 and its function in gastric carcinoma.
In this study, we demonstrated that miR-200c is an oncogene in gastric carcinoma which can directly inhibit the expression of 
Materials and methods

Cell lines and culture
The gastric epithelial-derived cancer cell lines AGS and BGC-823 were obtained from the cell repository for Academia Sinica (Shanghai). AGS cells were grown in Ham's F12 (Gibco, USA). BGC-823 cells were grown in RPMI1640 medium (Gibco, USA). The medium was supplemented with 10% fetal bovine serum (Gibco, USA). Both the cell lines were incubated in a humidified atmosphere containing 5% CO 2 at 37°C. 
RNA extraction and QRT-PCR
Western blotting
The protein level of P27 Kip1 was determined by Western blotting which was normalized by β-actin. In brief, the cells were lysed in RIPA buffer. Then the lysate was spun down and the supernatant was harvested. The concentration of the proteins was detected by BCA assay. Equal amounts of proteins were separated by SDS polyacrylamide gels and transferred onto membranes (Millipore), which were blocked with 5% non-fat milk protein for 1 h, then incubated with primary antibodies overnight at 4°C. The antibodies used were for P27 Kip1 (1:300, Santa Cruz Biotechnology) and β-actin (1:5,000, Sigma). The secondary antibodies were horseradish peroxidase-conjugated goat-anti-rabbit IgG (1:5,000, Santa Cruz Biotechnology). Immune complexes were detected by use of the Chemiluminescent HRP Substrate Kit (Millipore).
Luciferase assay
The mimics and the inhibitor of miR-220c were purchased from Ruibo (Guangzhou, China). The special fragment of the P27 Kip1 3′-UTR containing the miR-200c predicted target sites was synthesized by Invitrogen (USA). Then the fragment was cloned into the multiple cloning sites of the luciferase reporter pMIR-REPOTR (Applied Biosystems, USA), designated as pMIR-REPORT-P27-3′-UTR, which was also used in PCR to generate pMIR-REPORT-P27-3′-UTRmut plasmid with mutation of the binding sites on the 3′-UTR of P27
Kip1
. For the transfection of the palsmids, cells were seeded into 6-well plates (3 Â 10 5 cells/well) for 18-24 h. Then the plasmids were transfected by the use of Lipofectamine 3000 (Invitrogen, USA). To examine the direct conjugation of miR-200c to the 3′-UTR of P27 Kip1 , pMIR-REPORT-P27-3′-UTR and pMIR-RE-PORT-P27-3′-UTRmut were co-transfected into AGS cells with miR-200c mimics. pMIR-REPORT β-gal plasmid was used as a negative control. Luciferase activity in the cell lysates was determined by a single luciferase reporter assay (Promega, USA) 48 h after transfection, and target promoter-driven firefly luciferase activity was normalized to that of β-gal.
Clone formation assay
BGC-823 cells were incubated in 6-well plates for 18-24 h, which were transfected with the corresponding mimics/inhibitor for 48 h. Single cells were seeded on 6-well plates (300 cells/well). After 10 days of incubation, plates were stained with Giemsa for 20 min. The number of colonies with more than 50 cells was counted.
Patients and tissue specimens
Resected pairs of cancer tissue and distal normal gastric tissue (45 cm from the margin of the tumor) from 15 patients with gastric cancer were harvested during surgery at Qilu Hospital of Shandong University 2014-2015. None of the patients had received adjuvant chemotherapy before surgery. The diagnosis of gastric cancer was histopathologically confirmed. The general information for patients is in Table 1 . The study was approved by the ethics committee of Shandong University School of Medicine.
Immunohistochemistry
The expression of P27 Kip1 in human species was determined by
Immunohistochemistry. Resected tissue pairs were embedded with paraffin and sliced into 5-mm pieces, which were deparaffinized and dehydrated with xylene and a graded series of alcohol. Antigen retrieval was treated in 0.1 M citrate buffer at pH 6.0 with heating. Then 3% H 2 O 2 was used to block the endogenous peroxidase activity. The slides were incubated with goat serum for 30 min, then with rabbit anti-human P27 Kip1 (Santa Cruz, USA) overnight at 4°C. The results were detected with Diaminobenzidine (DAB) staining (Vector Laboratories, USA) which were calculated with the microscope images (Olympus BX60, Tokyo, Japan). 
Statistical analysis
Quantitative data are expressed as mean 7 SEM. Statistical analysis was in the use of SPSS 15.0 (SPSS, Inc., Chicago, IL) by twotailed Student's t-test. Statistical significance was set at Po 0.05. (Fig. 1A ), which repressed the mRNA level of P27 Kip1 without significant difference (Fig. 1B) . Similarly, the transfection of miR-200c inhibitor (Fig. 1C ) also did not obviously increase the mRNA expression of P27 Kip1 (Fig. 1D ). Then While with the inhibition of miR-200c, the P27 Kip1 protein level recovered to a higher level (Fig. 1E, F and G) . Therefore, miR-200c inhibited P27 Kip1 expression in the gastric cancer cells by degrading the protein level of P27 Kip1 .
Results
MiR
P27 Kip1 is the direct target of miR-200c
The complementary sequence of miR-200c was found on the 3′-UTR site of P27 Kip1 ( Fig. 2A) . Then the direct regulation of miR- wild-type 3′-UTR plasmid reduced the luciferase activity by approximately 60% relative to the control, whereas mutant 3′-UTR cotransfection almost restored the luciferase activity (Fig. 2B) . Thus, miR-200c directly targeted the binding site located at P27 Kip1 3′-UTR and P27 Kip1 is one of direct targets of miR-200c.
MiR-200c was involved in the proliferation of gastric cancer cells
Colony formation assay in BGC-823 cells revealed that the expression level of miR-200c truly affected the proliferation of gastric cancer cells (Fig. 3A) . The enforced expression of miR-200c enhanced the clone formation of cells, while the knockdown of miR-200c significantly inhibited the number of colonies (Fig. 3B) . Thus, miR-200c could work as an oncogene in human gastric cancer cells to activate cell proliferation.
MiR-200c expression was enhanced in human primary gastric cancer
We determined the expression of miR-200c in human primary gastric cancer specimens and matched normal tissues from 15 patients. HE staining showed the pathology of the samples (Fig. 4A) . QRT-PCR and IHC results showed that P27 Kip1 protein expression was inhibited in human gastric cancer specimens which was the same as the research before (Fig. 4A , B and C). At the same time, the level of miR-200c expression was enhanced in human gastric cancer samples (Fig. 4B) , which supported the oncogenetic role of miR-200c in vitro. Therefore, miR-200c and P27 Kip1 might be negative covalent in vivo (Fig. 4D) . We found no association of miR-200c or P27 Kip1 expression and patient age, gender or tumor size (Table 1 ).
Discussion
In this study, we showed that miR-200c played an oncogenetic role in human gastric carcinogenesis by directly downregulated the expression of P27 Kip1 and promoted the gastric cancer cell proliferation. Gastric cancer (GC) is one of the most common human malignant diseases and the second leading cause of tumor-related deaths worldwide [1, 2] . The incidence and mortality rate are particularly high in eastern Asia [3] . Despite recent advances in surgical techniques and adjuvant therapy after surgery, the 5-year survival rate is still low [25] . Carcinogenesis is a multi-factor, multi-phase and long-term interaction process on malignant transformation of normal cells. In this process, the abnormal regulation of cell cycle is involved in all the stages [26] . In previous studies, we have identified P27
Kip1 is an important target which could be regulated by different factors in the proliferation of gastric cancer cells, including H. pylori infection, the escape of cancer cells senescence, epigenetics, et al. [13, 14, 27] . We also find that P27 Kip1 can express in different cancer cell lines, which means it might be a valuable target for the diagnosis and treatment of gastric cancer. In most cancers, reduced levels of P27 Kip1 are correlated with increased tumor size, increased tumor grade, and a higher propensity for metastasis [28] . There might be different mechanisms by which levels of P27 Kip1 are regulated in different types of cancers. The expression level of P27 Kip1 can be regulated from the different steps of gene expression, such as transcription, translation and proteolysis [29] . P27 Kip1 can also be regulated by changing its subcellular location [30] . Both mechanisms act to reduce the inhibition effect of P27 Kip1 on the cell cycle, allowing for the activation of Cdk1 and Cdk2, which can begin the process of the cell cycle. We have identified that FoxM1 can inhibit the promoter activity of P27 Kip1 and thus is involved in gastric carcinoma. Since P27 Kip1 levels can also be moderated at the post transcriptional level, it has been proposed that P27 Kip1 may be regulated by miRNAs.
MiRNAs have recently been discovered as one of the crucial players in gastric carcinogenesis through posttranscriptional regulation of tumor suppressor and oncogenes [31] [32] [33] . A substantial number of deregulated miRNAs have been revealed in gastric cancer and the biological significance of those miRNAs has been confirmed in multiple functional experiments. Only a few researches focus on the cell cycle inhibitors. In this study, we first [19] . Similar studies have correlated low levels of p27 with a worse prognosis in breast cancer [20] . The correlations were also observed in patients with non-small cell lung cancer, colorectal cancer, and prostate cancer [21] [22] [23] . So P27 Kip1 can also be correlated with treatment response and work as a therapeutic target in cancer. In this study, we also identified the inhibition of P27 Kip1 expression in gastric carcinoma with the negative control of miR-200c. The antagomiRs of miR-200c that can block the activity of the miR-200c and allow for P27 Kip1 cell grow inhibition to take place might be a new way for gastric cancer treatment. In summary, our results showed that miR-200c, which could negatively regulate the expression of P27 Kip1 , was an important oncogene involved in the cell proliferation of gastric cancer. These findings may provide further information miR-200c to be useful as an anti-cancer therapeutic agent in gastric cancer.
